You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy

Citation Tools

Article menu
Clinical/translational cancer immunotherapy
Original research
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Olivo Pimentel V, Marcus D, van der Wiel AM, et al
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy
Journal for ImmunoTherapy of Cancer 2021;9:e001764. doi: 10.1136/jitc-2020-001764